Literature DB >> 17725991

Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration.

A B Moore1, L Castro, L Yu, X Zheng, X Di, M I Sifre, G E Kissling, R R Newbold, C D Bortner, D Dixon.   

Abstract

BACKGROUND: Due to dietary exposure of women to genistein, a soy-derived phytoestrogen, and the estrogen responsiveness of uterine leiomyomas 'fibroids', we evaluated the effects of genistein (0.001-50 microg/ml) on human uterine leiomyoma (UtLM) cells versus uterine smooth muscle cells (UtSMCs) in vitro.
METHODS: Light microscopy was used to determine the effects of genistein on cell morphology. Proliferation was assessed using a colorimetric assay and proliferating cell nuclear antigen (PCNA) immunocytochemistry. Flow cytometry was used to quantitate cells in the S-phase and those undergoing apoptosis. A fluorometric assay and confocal microscopy were used to detect caspase-3 activity and apoptotic bodies, respectively.
RESULTS: In UtLM cells, low concentrations (< or = 1 microg/ml) of genistein stimulated proliferation, increased PCNA labeling and the percentage of cells in the S-phase, but this did not occur in UtSMCs. Higher concentrations (> or = 10 microg/ml) of genistein adversely affected the morphology, significantly inhibited proliferation, decreased PCNA labeling, increased caspase-3 activity and induced apoptosis in both cell types.
CONCLUSIONS: Genistein's effects are concentration-dependent in both cell lines. Lower concentrations elicit proliferative effects on UtLM cells only; whereas, higher concentrations alter morphology, inhibit proliferation, and increase caspase activity and apoptosis in both cell types, with the latter two effects being more extensive in UtSMCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725991      PMCID: PMC2366995          DOI: 10.1093/humrep/dem185

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  47 in total

1.  17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway.

Authors:  A Barbarisi; O Petillo; A Di Lieto; M A Melone; S Margarucci; M Cannas; G Peluso
Journal:  J Cell Physiol       Date:  2001-03       Impact factor: 6.384

Review 2.  Effects of soy phytoestrogens genistein and daidzein on breast cancer growth.

Authors:  M L de Lemos
Journal:  Ann Pharmacother       Date:  2001-09       Impact factor: 3.154

3.  Genistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects.

Authors:  Lai See Po; Thomas T Wang; Zhen-Yu Chen; Lai K Leung
Journal:  Br J Nutr       Date:  2002-11       Impact factor: 3.718

4.  Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES).

Authors:  Retha R Newbold; Alicia B Moore; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2002 Sep-Oct       Impact factor: 1.902

5.  Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.

Authors:  M Maggiolini; D Bonofiglio; S Marsico; M L Panno; B Cenni; D Picard; S Andò
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

6.  Uterine adenocarcinoma in mice treated neonatally with genistein.

Authors:  R R Newbold; E P Banks; B Bullock; W N Jefferson
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

Review 7.  Clinical decision making regarding leiomyomata: what we need in the next millenium.

Authors:  A F Haney
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

8.  Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.

Authors:  X Chen; J J Anderson
Journal:  Nutr Cancer       Date:  2001       Impact factor: 2.900

9.  Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics.

Authors:  Sara A Carney; Hidetoshi Tahara; Carol D Swartz; John I Risinger; Hong He; Alicia B Moore; Joseph K Haseman; J Carl Barrett; Darlene Dixon
Journal:  Lab Invest       Date:  2002-06       Impact factor: 5.662

Review 10.  Genistein: does it prevent or promote breast cancer?

Authors:  K B Bouker; L Hilakivi-Clarke
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

View more
  24 in total

1.  An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.

Authors:  Xiaohua Gao; Linda Yu; Lysandra Castro; Alicia B Moore; Tonia Hermon; Carl Bortner; Maria Sifre; Darlene Dixon
Journal:  Toxicol Lett       Date:  2010-03-15       Impact factor: 4.372

2.  Glucocorticoids regulate gene expression and repress cellular proliferation in human uterine leiomyoma cells.

Authors:  Shannon Whirledge; Darlene Dixon; John A Cidlowski
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

3.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

4.  Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Authors:  Caitlin Fujisawa; John J Castellot
Journal:  J Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.782

Review 5.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

6.  Soy-derived isoflavones inhibit HeLa cell growth by inducing apoptosis.

Authors:  Jun-Xia Xiao; Guo-Qing Huang; Xin Geng; Hong-Wei Qiu
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

7.  A prospective study of dairy intake and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

8.  Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.

Authors:  Alicia B Moore; Linda Yu; Carol D Swartz; Xaiolin Zheng; Lu Wang; Lysandra Castro; Grace E Kissling; David K Walmer; Stanley J Robboy; Darlene Dixon
Journal:  Cell Commun Signal       Date:  2010-06-10       Impact factor: 5.712

9.  Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.

Authors:  Lara H El Touny; Partha P Banerjee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

10.  A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells.

Authors:  X Di; L Yu; A B Moore; L Castro; X Zheng; T Hermon; D Dixon
Journal:  Hum Reprod       Date:  2008-05-20       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.